参考文献/References:
[1] Maejima Y,Yokota S,Nishimori K,et al.The anorexigenic neural pathways of oxytocin and their clinical implication[J].Neuroendocrinology,2018,107(1):91-104.DOI:10.1159/000489263.
[2] Kerem L,Lawson EA.The effects of oxytocin on appetite regulation,food intake and metabolism in humans[J].Int J Mol Sci,2021,22(14):7737.DOI:10.3390/ijms22147737.
[3] Mccormack SE,Blevins JE,Lawson EA.Metabolic effects of oxytocin[J].Endocr Rev,2020,41(2):121-145.DOI:10.1210/endrev/bnz012.
[4] Skinner JA,Campbell EJ,Dayas CV,et al.The relationship between oxytocin,dietary intake and feeding:a systematic review and meta-analysis of studies in mice and rats[J].Front Neuroendocrinol,2019,52:65-78.DOI:10.1016/j.yfrne.2018.09.002.
[5] Anekonda VT,Thompson BW,Ho JM,et al.Hindbrain administration of oxytocin reduces food intake,weight gain and activates catecholamine neurons in the hindbrain nucleus of the solitary tract in rats[J].J Clin Med,2021,10(21):5078.DOI:10.3390/jcm10215078.
[6] Klockars A,Brunton C,Li L,et al.Intravenous administration of oxytocin in rats acutely decreases deprivation-induced chow intake,but it fails to affect consumption of palatable solutions[J].Peptides,2017,93:13-19.DOI:10.1016/j.peptides.2017.04.010.
[7] Klockars OA,Klockars A,Levine AS,et al.Oxytocin administration in the basolateral and central nuclei of amygdala moderately suppresses food intake[J].Neuroreport,2018,29(6):504-510.DOI:10.1097/WNR.0000000000001005.
[8] Skinner JA,Garg ML,Dayas CV,et al.Relationship between dietary intake and behaviors with oxytocin:a systematic review of studies in adults[J].Nutr Rev,2018,76(5):303-331.DOI:10.1093/nutrit/nux078.
[9] Aulinas A,Pulumo RL,Asanza E,et al.Endogenous oxytocin levels in relation to food intake,menstrual phase,and age in females[J].J Clin Endocrinol Metab,2019,104(4):1348-1356.DOI:10.1210/jc.2018-02036.
[10] Moghaddam SAP,Amiri P,Saidpour A,et al.The prevalence of food addiction and its associations with plasma oxytocin level and anthropometric and dietary measurements in iranian women with obesity[J].Peptides,2019,122:170151.DOI:10.1016/j.peptides.2019.170151.
[11] Ding C,Leow MK,Magkos F.Oxytocin in metabolic homeostasis:implications for obesity and diabetes management[J].Obes Rev,2019,20(1):22-40.DOI:10.1111/obr.12757.
[12] Szeto A,Cecati M,Ahmed R,et al.Oxytocin reduces adipose tissue inflammation in obese mice[J].Lipids Health Dis,2020,19(1):188.DOI:10.1186/s12944-020-01364-x.
[13] Lawson EA,Olszewski PK,Weller A,et al.The role of oxytocin in regulation of appetitive behaviour,body weight and glucose homeostasis[J].J Neuroendocrinol,2020,32(4):e12805.DOI:10.1111/jne.12805.
[14] Lawson EA.The effects of oxytocin on eating behaviour and metabolism in humans[J].Nat Rev Endocrinol,2017,13(12):700-709.DOI:10.1038/nrendo.2017.115.
[15] Espinoza SE,Lee JL,Wang CP,et al.Intranasal oxytocin improves lean muscle mass and lowers LDL cholesterol in older adults with sarcopenic obesity:a pilot randomized controlled trial[J].J Am Med Dir Assoc,2021,22(9):1877-1882.e2.DOI:10.1016/j.jamda.2021.04.015.
[16] Weingarten MFJ,Scholz M,Wohland T,et al.Circulating oxytocin is genetically determined and associated with obesity and impaired glucose tolerance[J].J Clin Endocrinol Metab,2019,104(11):5621-5632.DOI:10.1210/jc.2019-00643.
[17] Szulc P,Amri EZ,Varennes A,et al.High serum oxytocin is associated with metabolic syndrome in older men-the MINOS study[J].Diabetes Res Clin Pract,2016,122:17-27.DOI:10.1016/j.diabres.2016.09.022.
[18] Bush NR,Allison AL,Miller AL,et al.Socioeconomic disparities in childhood obesity risk:Association with an oxytocin receptor polymorphism[J].JAMA Pediatr,2017,171(1):61-67.DOI:10.1001/jamapediatrics.2016.2332.
[19] Qian W,Zhu T,Tang B,et al.Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients[J].J Clin Endocrinol Metab,2014,99(12):4683-4689.DOI:10.1210/jc.2014-2206.
[20] Eisenberg Y,Dugas LR,Akbar A,et al.Oxytocin is lower in african american men with diabetes and associates with psycho-social and metabolic health factors[J].PLoS One,2018,13(1):e0190301.DOI:10.1371/journal.pone.0190301.
[21] Papazoglou I,Lee JH,Cui Z,et al.A distinct hypothalamus-to-β cell circuit modulates insulin secretion[J].Cell Metab,2022,34(2):285-298.e7.DOI:10.1016/j.cmet.2021.12.020.
[22] Mohan S,Khan D,Moffett RC,et al.Oxytocin is present in islets and plays a role in beta-cell function and survival[J].Peptides,2018,100:260-268.DOI:10.1016/j.peptides.2017.12.019.
[23] Lawson EA,Marengi DA,Desanti RL,et al.Oxytocin reduces caloric intake in men[J].Obesity(Silver Spring),2015,23(5):950-956.DOI:10.1002/oby.21069.
[24] Klement J,Ott V,Rapp K,et al.Oxytocin improves β-cell responsivity and glucose tolerance in healthy men[J].Diabetes,2017,66(2):264-271.DOI:10.2337/db16-0569.
[25] Thienel M,Fritsche A,Heinrichs M,et al.Oxytocin's inhibitory effect on food intake is stronger in obese than normal-weight men[J].Int J Obes(Lond),2016,40(11):1707-1714.DOI:10.1038/ijo.2016.149.
[26] Brede S,Fehr S,Dalla-Man C,et al.Intranasal oxytocin fails to acutely improve glucose metabolism in obese men[J].Diabetes Obes Metab,2019,21(2):424-428.DOI:10.1111/dom.13527.
[27] Zhang H,Wu C,Chen Q,et al.Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models[J].PLoS One,2013,8(5):e61477.DOI:10.1371/journal.pone.0061477.
[28] Altirriba J,Poher AL,Caillon A,et al.Divergent effects of oxytocin treatment of obese diabetic mice on adiposity and diabetes[J].Endocrinology,2014,155(11):4189-4201.DOI:10.1210/en.2014-1466.
[29] Chang HH,Chang WH,Chi MH,et al.The OXTR polymorphism stratified the correlation of oxytocin and glucose homeostasis in non-diabetic subjects[J].Diabetes Metab Syndr Obes,2019,12:2707-2713.DOI:10.2147/DMSO.S226245.
[30] Rung JM,Horta M,Tammi EM,et al.Safety and tolerability of chronic intranasal oxytocin in older men:results from a randomized controlled trial[J].Psychopharmacology(Berl),2021,238(9):2405-2418.DOI:10.1007/s00213-021-05862-3.
相似文献/References:
[1]罗俊婷 胡欣 陈国芳 刘超.骨膜蛋白与代谢性疾病[J].国际内分泌代谢杂志,2018,38(01):26.[doi:10.3760/cma.j.issn.1673-4157.2018.01.007]
Luo Junting,Hu Xin,Chen Guofang,et al.Periostin and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(01):26.[doi:10.3760/cma.j.issn.1673-4157.2018.01.007]
[2]夏心怡 张洪梅.肠道菌群及其代谢产物调节糖脂代谢的机制[J].国际内分泌代谢杂志,2018,38(05):309.[doi:10.3760/cma.j.issn.1673-4157.2018.05.006]
Xia Xinyi,Zhang Hongmei.Regulating mechanism of glycolipid metabolism by intestinal microbiota and its metabolites[J].International Journal of Endocrinology and Metabolism,2018,38(01):309.[doi:10.3760/cma.j.issn.1673-4157.2018.05.006]
[3]沈祯敏 邵莉.整合素相关蛋白及其配体在糖脂代谢中的作用[J].国际内分泌代谢杂志,2018,38(05):336.[doi:10.3760/cma.j.issn.1673-4157.2018.05.013]
Shen Zhenmin,Shao Li.Roles of integrin associated protein and its ligands in glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2018,38(01):336.[doi:10.3760/cma.j.issn.1673-4157.2018.05.013]
[4]严克敏 朱惠娟 龚凤英.红花黄色素改善肝功能和糖脂代谢作用的研究进展[J].国际内分泌代谢杂志,2019,39(02):97.[doi:10.3760/cma.j.issn.1673-4157.2019.02.006]
Yan Kemin,Zhu Huijuan,Gong Fengying.Advances in the roles of safflower yellow in improving liver function and glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2019,39(01):97.[doi:10.3760/cma.j.issn.1673-4157.2019.02.006]
[5]郭青玉 邵加庆.大黄酸改善糖脂代谢的相关机制[J].国际内分泌代谢杂志,2019,39(03):207.[doi:10.3760/cma.j.issn.1673-4157.2019.03.015]
Guo Qingyu,Shao Jiaqing.Related mechanisms of Rhein improving glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2019,39(01):207.[doi:10.3760/cma.j.issn.1673-4157.2019.03.015]
[6]杜苏苏,李晓南.姜黄素对非酒精性脂肪性肝病的调控作用[J].国际内分泌代谢杂志,2020,40(06):399.[doi:10.3760/cma.j.cn121383-20200117-01026]
Du Susu,Li Xiaonan.Regulatory effects of curcumin on nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2020,40(01):399.[doi:10.3760/cma.j.cn121383-20200117-01026]
[7]梁源,孙立君,尹悦,等.消化内分泌与糖脂代谢[J].国际内分泌代谢杂志,2021,41(04):290.[doi:10.3760/cma.j.cn121383-20210415-05028]
Liang Yuan,Sun Lijun,Yin Yue,et al.Gut endocrine in glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2021,41(01):290.[doi:10.3760/cma.j.cn121383-20210415-05028]
[8]李小红,陈频.新型脂肪细胞因子Metrnl在糖脂代谢中作用的研究进展[J].国际内分泌代谢杂志,2022,42(02):138.[doi:10.3760/cma.j.cn121383-20201027-10034]
Li Xiaohong,Chen Pin..Research progress on the role of novel secretory adipokine-Metrnl in glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2022,42(01):138.[doi:10.3760/cma.j.cn121383-20201027-10034]
[9]胡雯婧,朱惠娟,龚凤英.成纤维细胞生长因子21治疗肥胖症及其相关代谢性疾病的研究进展[J].国际内分泌代谢杂志,2023,43(02):117.[doi:10.3760/cma.j.cn121383-20220125-01048]
Hu Wenjing,Zhu Huijuan,Gong Fengying..Research progress of fibroblast growth factor 21 in the treatment of obesity and its associated metabolic diseases[J].International Journal of Endocrinology and Metabolism,2023,43(01):117.[doi:10.3760/cma.j.cn121383-20220125-01048]